Pharmaceutical Outsourcing Market Trends & Competitive Analysis 2024-2033
The advanced therapeutics pharmaceutical outsourcing global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Advanced Therapeutics Pharmaceutical Outsourcing Market, 2024 report by The
Business Research Company offers comprehensive insights into the current state
of the market and highlights future growth opportunities.
Market Size -
The advanced therapeutics pharmaceutical outsourcing market size has grown
strongly in recent years. It will grow from $7.64 billion in 2023 to $8.07
billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be
attributed to growth in biopharmaceutical infrastructure, regulatory
compliance, increasing demand for novel drugs to treat chronic and
life-threatening diseases, improved efficiency, and growing demand for
personalized medicine.
The advanced therapeutics pharmaceutical outsourcing market size is expected to
see steady growth in the next few years. It will grow to $9.76 billion in 2028
at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be
attributed to The increasing adoption of cell and gene therapies, The
increasing focus on mRNA therapies, rising demand for cutting-edge treatments,
improved efficiency and cost-effective solutions provided by outsourcing
partners, and collaborative innovation. Major trends in the forecast period
include technological advancement, rising expertise in advanced therapeutics,
escalating pipeline of innovative therapies, the integration of cutting-edge
technology, rapid advancements in gene therapy, cell therapy, and mRNA
technologies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report
Scope Of Advanced Therapeutics Pharmaceutical Outsourcing Market
The Business Research Company's reports encompass a wide range of information,
including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Advanced Therapeutics Pharmaceutical Outsourcing Market Overview
Market Drivers -
The increasing adoption of cell and gene therapies is expected to propel the
growth of the advanced therapeutics pharmaceutical outsourcing market going
forward. Cell and gene therapies are innovative treatments that use living
cells or genetic material to treat or cure diseases. Advanced therapeutics
pharmaceutical outsourcing is used in cell and gene therapies to offer access
to providers with proven track records and experienced personnel, saving
companies time and resources in building their teams. For instance, in November
2023, according to a report by Nature, a UK-based scientific journal, the
number of new patients treated with gene therapies is expected to increase from
16,244 in 2020 to 94,696 in 2025. Therefore, the increasing adoption of cell
and gene therapies is driving the growth of the advanced therapeutics
pharmaceutical outsourcing market.
Market Trends -
Major companies operating in the advanced therapeutics pharmaceutical
outsourcing market are focusing on strategic partnerships to provide reliable
services to customers. A strategic partnership is a collaborative arrangement
between two or more entities (typically businesses) formed to achieve mutually
beneficial goals that each partner could not achieve independently. For
instance, in January 2023, Lonza, a Switzerland-based manufacturing company for
the pharmaceutical, biotechnology, and nutrition sectors, partnered with
Context Therapeutics Inc., a US-based biopharmaceutical company advancing
medicines for solid tumors. The partnership involves Lonza providing
manufacturability assessment, gene, and cell line construction, and process
development for the drug substance and drug product.
The advanced therapeutics pharmaceutical outsourcing market covered in this
report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract
Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other
Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial
Manufacturing And Packaging
Get an inside scoop of the advanced therapeutics pharmaceutical outsourcing
market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
Regional Insights -
North America was the largest region in the advanced therapeutics
pharmaceutical outsourcing market in 2023. The regions covered in the advanced
therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western
Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies -
Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings,
IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi
AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International,
Recipharm AB, Croda International Plc, Samsung Biologics, Vetter Pharma
International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies,
Marken, AGC Biologics, Evotec SE, ProPharma Group, Piramal Pharma Solutions,
Corden Pharma International LLC, Novotech Pty Ltd., Cryoport Systems Inc.,
Cytovance Biologics
Table of Contents
1. Executive Summary
2. Advanced Therapeutics Pharmaceutical Outsourcing Market Report Structure
3. Advanced Therapeutics Pharmaceutical Outsourcing Market Trends And
Strategies
4. Advanced Therapeutics Pharmaceutical Outsourcing Market – Macro Economic
Scenario
5. Advanced Therapeutics Pharmaceutical Outsourcing Market Size And Growth
…..
27. Advanced Therapeutics Pharmaceutical Outsourcing Market Competitor
Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
Comments
Post a Comment